Company / Current Liabilities per Share
Xenon Pharmaceuticals Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.53
FY2025
5-year range
$0.33 / $0.53
FY2021-FY2025
Trend
+15.4%
vs FY2024
Sector context
#152 of 210
Health Care
What the data says
At $0.53, Xenon Pharmaceuticals Inc.'s current liabilities per share ranks #59 of 210 in the Health Care sector. Current Liabilities per Share has increased for 4 consecutive years, from $0.33 in FY2021 to $0.53 in FY2025.
Based on SEC 10-K filings.
0.53 in FY2025 with a 5-year CAGR of +4.3%.
Increased from $0.41 to $0.53 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
#59 of 210 in Health CareTop 28% of 210This company $0.53 Sector average $23.79
▼
-97.8% below sector average
Key checks
Key Insights
- Xenon Pharmaceuticals Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 15.4% year-over-year.
- Ranks #152 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.53 | +15.4% |
| FY2024 | $0.46 | +12.1% |
| FY2023 | $0.41 | +8.7% |
| FY2022 | $0.37 | +14.2% |
| FY2021 | $0.33 | -23.3% |
| FY2020 | $0.43 | -74.4% |
| FY2019 | $1.67 | +630.7% |
| FY2018 | $0.23 | +0.5% |
| FY2017 | $0.23 | -8.7% |
| FY2016 | $0.25 | +27.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026